Buy Voxzogo (vosoritide) Online For Sale

$8,486.00

DISEASE INDICATIONS: Achondroplasia

MANUFACTURER: BioMarin Europe Ltd

USAGE: Subcutaneous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Voxzogo is a prescription medication that is used to treat achondroplasia in children aged 2 to 18, a genetic disorder that causes short stature and bone deformities. Developed by BioMarin Pharmaceutical, Voxzogo stimulates bone growth by binding to the CNP receptor, which is involved in regulating bone growth.

Buy Roszet (rosuvastatin and ezetimibe) Online For Sale

DISEASE INDICATIONS: Hypercholesterolemia

MANUFACTURER: Althera Life Sciences

USAGE: Oral

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Roszet is a medication used to reduce LDL-C in adults with high blood cholesterol or hypercholesterolemia. It is a combination of two active ingredients, rosuvastatin and ezetimibe, that work differently to reduce the amount of LDL-C in the bloodstream

Buy Zegalogue (dasiglucagon) Online For Sale

From $292.00

DISEASE INDICATIONS: Diabetes

MANUFACTURER: Zeeland Pharma

USAGE: Subcutaneous

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Zegalogue (dasiglucagon) is a medication used to treat severe hypoglycemia in people with diabetes, approved by the US Food and Drug Administration in March 2021. It is a soluble glucagon analog that can be injected via a prefilled, single-use injector device, and stimulates the liver to increase blood sugar levels.

Buy Kerendia (finerenone) Online

From $577.00

Kerendia is the brand name for the medication with the active ingredient finerenone. It is a prescription medication used to treat chronic kidney disease (CKD) in adults with type 2 diabetes.

Buy Evkeeza (evinacumab) Online For Sale

DISEASE INDICATIONS: Hypercholesterolemia

MANUFACTURER: Regeneron Pharmaceuticals, Inc.

USAGE: Intravenous

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Evkeeza (evinacumab) is a prescription medication used to treat adults and adolescents aged 12 years and older with homozygous familial hypercholesterolemia (HoFH). HoFH is a rare genetic disorder that causes very high cholesterol levels in the blood.

Buy Leqvio (inclisiran) Online For Sale

$2,493.00

DISEASE INDICATIONS: Hypercholesterolemia

MANUFACTURER: Novartis

USAGE: Subcutaneous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Leqvio (inclisiran) is a prescription medication used to lower cholesterol levels in adults with primary hypercholesterolemia or mixed dyslipidemia (conditions that cause high levels of fats, including cholesterol, in the blood). It is also used to treat heterozygous familial hypercholesterolemia (a genetic condition that causes high cholesterol).

Buy Oxlumo (lumasiran) Online For Sale

$59,838.00

DISEASE INDICATIONS: Primary hyperoxaluria type 1 (PH1)

MANUFACTURER: Alnylam Pharmaceuticals

USAGE: Subcutaneous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Oxlumo (lumasiran) is a newly approved medication used for treating primary hyperoxaluria type 1 (PH1), a rare genetic disorder that causes a build-up of oxalate in the body leading to severe health problems. Oxlumo reduces the production of glycolate oxidase, an enzyme that leads to the accumulation of oxalate in individuals with PH1 and prevents kidney damage.

Buy Zokinvy (lonafarnib) Online For Sale

From $29,309.00

DISEASE INDICATIONS: Progeria

MANUFACTURER: Eiger Biopharmaceuticals

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Zokinvy (lonafarnib) is a medication used for treating Hutchinson-Gilford Progeria Syndrome (HGPS), a genetic disorder that accelerates aging in children. HGPS is caused by a mutation in the lamin A gene, leading to a build-up of a toxic protein called progerin in the body.

Buy Isturisa (osilodrostat) Online For Sale

From $1,697.00

DISEASE INDICATIONS: Primary Biliary Cholangitis (PBC)

MANUFACTURER: Novartis

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Isturisa (osilodrostat) is a drug utilized in the cure of grown-up individuals affected by Cushing’s syndrome or for grown-ups with Cushing’s disease who are ineligible for surgery or did not have a positive response to surgery done previously.